Archive

Hospital-acquired infections remain untracked nationally, risking thousands of preventable deaths and silent outbreaks in public hospitals.

Discovery Health claims will now be covered by the scheme after a processing error led to member outcry and regulatory scrutiny.

European drug pricing dispute heats up as pharma giants demand higher returns after US price cuts. Tensions are on the rise.

Discovery Health claims error prompts backlash as 16,000 members face repayments. Critics question the administrative failure.

GEMS tariff intervention planned as government responds to sharp price hikes affecting public service members and affordability pressures.

Medscheme Bonitas legal battle over administrator RFPs intensifies as CMS probe and governance concerns cloud SA’s healthcare procurement.

NHLS cancer test outsourcing cost R116m to clear backlogs, raising sustainability concerns amid tight healthcare budgets.

AfroCentric divests Activo Health to FHC Group as it refocuses on health services and administration in a major portfolio shift.

Global malaria crisis worsens as US aid cuts, rising resistance, and stalled progress put millions, especially children, at deadly risk.

Dis-Chem’s personalised healthcare model uses AI and data to offer tailored care, rewards, and insurance – reshaping retail pharmacy.

Aspen APAC divestment unlocks R26.5bn in capital, sharpening the group’s focus on GLP-1 injectables and reducing net debt heading into 2026.